Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg EMA starts review of VIR-7831 for treating patients with COVID-19 15 april 2021NewsHumanCOVID-19Medicines AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets 14 april 2021NewsHumanCOVID-19Vaccines COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues 14 april 2021NewsHumanCOVID-19Vaccines IT systems intermittently unavailable from 16 to 18 April 2021 14 april 2021NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021 9 april 2021NewsHumanCOVID-19PharmacovigilanceReferrals AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 7 april 2021NewsHumanCOVID-19Vaccines AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues 31 maart 2021NewsHumanCOVID-19Vaccines EU recommendations for 2021-2022 seasonal flu vaccine composition 30 maart 2021NewsHumanMedicinesVaccines EMA working on COVID-19 over holiday period 30 maart 2021NewsCorporateCOVID-19 Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 26 maart 2021NewsHumanCOVID-19Vaccines 1 … 68 69 70 71 72 Page 72 of 385 73 74 75 76 … 385
EMA starts review of VIR-7831 for treating patients with COVID-19 15 april 2021NewsHumanCOVID-19Medicines
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets 14 april 2021NewsHumanCOVID-19Vaccines
COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues 14 april 2021NewsHumanCOVID-19Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021 9 april 2021NewsHumanCOVID-19PharmacovigilanceReferrals
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 7 april 2021NewsHumanCOVID-19Vaccines
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues 31 maart 2021NewsHumanCOVID-19Vaccines
EU recommendations for 2021-2022 seasonal flu vaccine composition 30 maart 2021NewsHumanMedicinesVaccines
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 26 maart 2021NewsHumanCOVID-19Vaccines